First report of a cefepime-resistant Escherichia coli clinical isolate carrying bla_CMY-33 from Brazil

J Glob Antimicrob Resist. 2019 Sep:18:153-154. doi: 10.1016/j.jgar.2019.07.004. Epub 2019 Jul 12.

Authors

Herrison Fontana¹, Larissa Brasil Skaf¹, Ana Filipa Moreira Martins¹, Laís Lisboa Corrêa¹, Beatriz Meurer Moreira¹, Raquel Regina Bonelli²

Affiliations

¹ Instituto de Microbiologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
² Instituto de Microbiologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. Electronic address: raquel.bonelli@micro.ufrj.br.

PMID: 31306815
DOI: 10.1016/j.jgar.2019.07.004

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Anti-Bacterial Agents / pharmacology*
Brazil
Cefepime / pharmacology*
Escherichia coli / drug effects*
Escherichia coli / enzymology*
Escherichia coli / isolation & purification
Escherichia coli Infections / microbiology
Escherichia coli Infections / urine
Female
Humans
Microbial Sensitivity Tests
Urinary Tract Infections / diagnosis
Urinary Tract Infections / microbiology
beta-Lactamases

Substances

Anti-Bacterial Agents
Cefepime
beta-Lactamases